What is ARK Genomic Revolution UCITS ETF Class A USD Accumulation
ARK Genomic Revolution UCITS ETF Class A USD Accumulation falls under the Sector Equity Biotechnology category, with the top three holdings being Twist Bioscience Corp (10.1%), Tempus AI, Inc. Class A Common Stock (8.7%) and 10X Genomics Inc (6.6%). Over the past 12 months, the fund has returned +97.5%.
Frequently asked questions
Does this ETF pay dividends or reinvest them?
The distribution policy (accumulating or distributing) isn't available in our data sheet at the moment; check the fund's KID/KIID on the issuer's website for this information.
What's the annual cost (TER) of this ETF?
This ETF's TER (Total Expense Ratio) is 0.75% annual — the annual fee deducted automatically by the fund, already reflected in the price.
How is this ETF taxed in the UK?
Held outside an ISA or SIPP, gains are generally subject to Capital Gains Tax and income may be subject to dividend tax depending on the fund's distribution policy — see our dedicated UK tax guide. Held within an ISA, both are entirely exempt.
